- Israel Chemicals (NYSE:ICL) says it completed a sale of its 50% stake in water desalination firm IDE Technologies for $167M, below an initial agreement of $178M.
- ICL says it expects to post a $40M capital gain in Q4 from the sale.
- IDE, which has built major desalination plants in the U.S., Israel, India and China, is jointly owned by ICL and Israeli firm Delek Group.